Ultralife Corporation (ULBI) is trading firmly above its key moving averages, with the price at $7.38, higher than the MA-20 at $6.53, MA-50 at $6.80, and MA-200 at $6.45. This confirms a bullish trend across short, medium, and long-term horizons.
Highlights
- Ultralife is exhibiting a broadly bullish technical trend, consistently trading above major moving averages across all horizons.
- The stock faces key resistance near 7.50 and strong support at 6.85, forming a defined trading corridor.
- Short-term indicators signal overbought conditions and elevated intraday volatility, suggesting risk of a near-term pullback despite bullish momentum.
Support at Kijun with overbought signals as upward momentum slows
Nearest dynamic support is at the Ichimoku Kijun level of $6.85, with resistance now shifting toward the MA-50 level and next round figures near $7.50. Momentum is moderately positive with the MACD hovering neutral and the ADX still below the trend-confirmation threshold. RSI remains supportive at 57.57, but Stochastic RSI signals overbought, and CCI is close to the overbought zone. Bull/Bear Power above zero signals clear buyer dominance, yet also shows an overbought reading, suggesting buying strength but rising risk of near-term reversal. The Awesome Oscillator aligns with the broader bullish bias. Today, the stock is up 2.07% to $7.38 after opening with a downside gap of about $0.07, now trading toward the upper part of the daily range. Intraday volatility stands at 4.78%. The session reflects strength toward highs despite some near-term oscillator divergence, as price action is confirming underlying bullish momentum.
Earlier, analysts noted that Ultralife’s technical structure remained bullish but cautioned that overbought signals could limit immediate upside momentum. The current analysis reinforces this view by demonstrating underlying trend strength despite short-term oscillator divergence, with a break and sustained move above $7.72 now emerging as the critical threshold for confirming the next bullish phase.
Latest Ultralife News
- Forex
- Crypto